Johnson & Johnson's McNeil Consumer Healthcare Division, with headquarters and a factory in Fort Washington, is still issuing recalls of products.
This week, McNeil recalled certain lots of Motrin IB coated caplets and tablets in three packaging sizes.
The lot numbers are posted on McNeil's statement on its Motrin site, with the specific page here. The lot numbers are on the side of the carton.
The products were distributed in the United States, Puerto Rico, Bahamas, Fiji, Belize, St. Lucia and Jamaica.
J&J said earlier this year that it is spending $100 million to fix the manufacturing problems at the three McNeil plants, which are in Fort Washington, Lancaster and Las Piedras, Puerto Rico. The U.S. Food and Drug Administration found violations of the Food, Drug and Cosmetic Act in 2009 and 2010, which prompted the closing of the Fort Washington plant in 2010. That plant is still not producing medicines. The Lancaster and Las Piedras plants are operating, but under greater supervision that is part of the consent decree agreed to by the company after negotiations with prosecutors from the U.S. Justice Department and the FDA. The FDA news release on the consent decree is here.
The latest recall is because some tablets and caplets might not dissolve as quickly as intended when nearing the expiration date.
In its statement on Wednesday, McNeil said consumers do not need to dispose of, or return, the product and that "there is no safety concern if consumers continue taking the product in accordance with its label; however, it is possible there may be a delay in experiencing relief. This action is not being undertaken on the basis of adverse events."